V8 Peptides — Engineered Performance
Research Library
BPC-157 and TB-500 Testing: What a Certificate Must Show
BPC-157Quality & Testing

BPC-157 and TB-500 Testing: What a Certificate Must Show

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

What should third-party testing show for BPC-157 and TB-500? A lot-matched certificate from an identifiable independent laboratory with a named HPLC purity method, an identity result by mass (BPC-157 about 1419.5 Da, [M+2H]2+ near m/z 710.4; the TB-500 fragment Ac-LKKTETQ about 889 Da, [M+2H]2+ near m/z 445.3), a test date and a reference the laboratory can confirm. HPLC purity is not net peptide content, and TB-500 needs an explicit sequence because the name covers different forms. For laboratory research use only.

"Third-party tested" is printed on almost every research peptide listing, and it says almost nothing until you know what was tested, by which method, on which lot and whether you can inspect the report. For BPC-157 and TB-500 the question has compound-specific answers, because the two molecules have different masses, different sequence features and, in the case of TB-500, an identity ambiguity that a purity percentage cannot resolve. This article is a verification guide for those two peptides: which analytical statements to look for on a certificate, what numbers a correct identity result should produce, and which questions a certificate cannot answer. For the general principles see third-party testing explained and the existing BPC-157 and TB-500 testing overview; this piece adds the compound-specific checks and a worked identity calculation. All materials are for laboratory research use only.

What "independent" has to mean

Independence means the laboratory that produced the report has no stake in the result and that the report can be confirmed with that laboratory. A useful certificate carries a lot number that matches the vial, a named method for each result, an identifiable laboratory, a test date and, ideally, a lab sample code or similar reference that allows the issuing laboratory to confirm it issued that report for that lot. This site’s COA library lists published certificates with a lot number, publication date and lab sample code, and the BPC-157 product page links the certificate for its listed lot. The TB-500 product page, at the time of writing, shows the certificate as in progress, which means a TB-500 buyer should check the library for the lot in hand rather than assume a certificate exists.

The standard against which any claim should be judged is simple: could a stranger take the certificate, the lot number and the lab reference, and confirm the result without asking the seller? If not, regard the claim as marketing. How to read a COA walks through the fields.

The analytical statements that matter, in order

Three questions are answered by different methods, and a certificate that answers only one of them is incomplete for a compound-identity decision.

QuestionUsual methodWhat the result looks likeWhat it does not tell you
How much of the material is the main component?Reversed-phase HPLC with UV detectionA chromatogram with one dominant peak and a purity as percent of total peak areaNet peptide content, identity, co-eluting impurities, non-UV-absorbing contaminants
Is it the right molecule?Mass spectrometry (identity), sometimes amino acid analysis or sequencingMeasured mass or m/z values matching the theoretical values within tolerancePurity, or stereochemistry (racemized residues have the same mass)
Is it free of contaminants a chromatogram cannot see?Endotoxin (LAL) and sterility testing; residual solvent and counterion analysisPass/fail or quantitative values against stated limitsPeptide-related impurities

D’Hondt and colleagues (2014) review the impurity classes in synthetic peptides, including truncated and deletion sequences, insertion sequences, incompletely deprotected products, racemized residues and counterion or solvent residues, and show that HPLC, mass spectrometry and other orthogonal methods are used in combination because no single method sees all of them. That is the reason a single purity percentage is not a complete description. For the method comparison see HPLC vs mass spectrometry and understanding HPLC purity.

Worked identity check for BPC-157

An identity result is only meaningful if the reader knows what to expect. BPC-157 is the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, with formula C62H98N16O22. The sum of the amino acid residue masses plus one water gives a monoisotopic mass of about 1418.704 Da and an average mass of about 1419.5 Da. In positive-ion electrospray mass spectrometry, expect the singly protonated ion [M+H]+ at m/z about 1419.711 and the doubly protonated ion [M+2H]2+ at about 710.359, with the second the more informative in many instruments because short peptides with a lysine charge easily. A measured value within the instrument’s stated tolerance of those numbers is consistent with the sequence; a series of lower masses suggests truncation or deletion sequences, and an unexpected mass shift should be explained by the laboratory before the lot is accepted. Cox and colleagues (2017), working on detection of confiscated BPC-157 by LC-MS/MS, report the same sequence and describe a stable metabolite whose measurement improved specificity, which illustrates how a second mass signal supports an identity claim.

Mass alone cannot distinguish isomers, such as a peptide with an isoaspartyl linkage or a D-amino acid, so HPLC retention behavior and a reference standard still matter.

Worked identity check for TB-500, and why it needs more care

"TB-500" is not used for one molecule only. In the doping-control literature, Ho and colleagues (2012) describe TB-500 as a synthetic version of an active region of thymosin beta-4 and developed methods for the N-acetylated fragment Ac-LKKTETQ (residues 17-23) in equine samples. Thymosin beta-4 itself is a 43-residue protein of about 4.96 kDa with an N-terminal acetyl group (Goldstein et al., 2012; Huff et al., 2001), a different molecule from the fragment. The V8 product page and the library’s overview identify the supplied material as the 17-23 fragment, Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln, formula C38H68N10O14, about 889 Da. A buyer or a reviewer who sees only the words "TB-500 purity ≥98%" cannot tell which molecule was measured.

The expected ions for the fragment are a monoisotopic mass of about 888.492 Da, [M+H]+ at m/z about 889.499 and [M+2H]2+ at about 445.253. A result near 4,960 Da or a multiply charged envelope typical of a 43-residue protein would indicate the full-length protein, not the fragment. The same caution applies in reverse when a certificate lists a peptide name without a mass. The practical rule: for TB-500, require an identity statement that gives the sequence or formula and a measured mass, and compare it with the numbers above.

Checking a certificate: a field-by-field list

The checklist below can be applied to any certificate for either peptide. Items marked as compound-specific use the expected values worked out above.

FieldWhat to look forCompound-specific note
Lot numberMatches the vial label exactlyRecord both in the notebook
Laboratory and reference codeIdentifiable laboratory; a code the laboratory can confirmUse the verification route the laboratory provides
Test datePlausible relative to the lot’s manufactureA report reflects one sample on one date
Purity by HPLCMethod named; chromatogram shown; purity as percent peak areaProduct specification is ≥98% for both
IdentityMeasured mass or m/z with the expected valuesBPC-157: m/z about 1419.7 / 710.4. TB-500 fragment: m/z about 889.5 / 445.3
Sequence confirmationStated, with the methodTB-500 needs it most because the name is ambiguous
Endotoxin and sterilityMethod and result, if includedA chromatogram does not cover these
Supplied form and storageMatches the product pageLyophilized powder, 2–8 °C, −20 °C long-term

Two limits apply to every certificate. A report reflects a sample, not every vial. And HPLC purity is a percentage of chromatographic peak area, not a percentage of the powder: counterions and residual water also occupy mass, so net peptide content is lower. If a concentration-critical experiment depends on the exact amount of peptide, quantify the stock rather than relying on the labeled mass.

Verifying a lot yourself

Documentation can be complemented by the laboratory’s own measurements. A minimal in-house check on a new lot is a reversed-phase HPLC run of the reconstituted stock against a retained reference or the previous lot, comparing retention time, peak shape and area; LC-MS if the equipment is available, to confirm the masses listed above; and a visual record of the vial and solution. Sending a blinded sample to an outside laboratory is the strongest check and is appropriate where a result will be published. Whichever route is used, handle the stock by a defined method (how to reconstitute a lyophilized peptide), compute concentrations with the reconstitution calculator, and keep the report with the lot record.

A new laboratory evaluating suppliers more broadly will find the supplier vetting guide useful, and BPC-157 purity testing covers the single-compound case. The mass values here are calculated from sequences and should be checked against your own instrument’s tolerance and calibration.

Frequently asked questions

What does third-party tested mean for a research peptide?

A laboratory independent of the seller analyzed a sample and issued a report. It is meaningful only if the report names its methods, is tied to the lot and can be confirmed with the issuing laboratory.

What tests should a BPC-157 or TB-500 certificate include?

HPLC purity with a named method, an identity result by mass spectrometry or another method, a lot number and test date, and ideally endotoxin and sterility results.

What mass should BPC-157 show?

Average mass about 1419.5 Da; monoisotopic [M+H]+ at m/z about 1419.711 and [M+2H]2+ at about 710.359, calculated from C62H98N16O22.

What mass should the TB-500 fragment show?

The fragment Ac-LKKTETQ has a monoisotopic mass of about 888.492 Da, [M+H]+ at m/z about 889.499 and [M+2H]2+ at about 445.253, from C38H68N10O14.

Why is TB-500 identity harder to confirm?

The name is used for different molecular forms: the 17-23 fragment and, loosely, thymosin beta-4 itself, a 43-residue protein of about 4.96 kDa. A certificate needs to state the sequence or formula and a measured mass.

Does ≥98% HPLC purity mean 98% of the powder is peptide?

No. It means about 98% of the chromatographic peak area belongs to the main component. Counterions and residual water also take up mass, so net peptide content is lower.

Can mass spectrometry detect every impurity?

No. Isomers such as isoaspartyl or D-amino acid variants share the same mass, so HPLC retention and reference standards still matter. Orthogonal methods are used together.

Is a certificate enough to trust every vial?

A report reflects one sample on one date. Lot-matched documentation plus your own checks on the received lot gives a stronger basis.

How can I verify a lot in my own laboratory?

Run reversed-phase HPLC on the reconstituted stock against a reference, confirm masses by LC-MS if available, and send a blinded sample to an outside laboratory for work that will be published.

Where are the certificates for this site’s lots?

In the COA library, which lists each published lot with its publication date and a lab sample code. Some products show certificates as in progress, so check the lot in hand.

Related reading: Why BPC-157 and TB-500 Are Paired in Research, BPC-157 and TB-500: Reading Preclinical Parameters, BPC-157 Complete Research Guide: Evidence and Handling.

References

  1. D’Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2-30. doi:10.1016/j.jpba.2014.06.012
  2. Ho EN, Kwok WH, Lau MY, et al. Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4, in equine urine and plasma by liquid chromatography-mass spectrometry. J Chromatogr A. 2012;1265:57-69. doi:10.1016/j.chroma.2012.09.043
  3. Cox HD, Miller GD, Eichner D. Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H by LC-MS/MS. Drug Test Anal. 2017;9(10):1490-1498. doi:10.1002/dta.2152
  4. Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12(1):37-51. doi:10.1517/14712598.2012.634793
  5. Huff T, Müller CSG, Otto AM, Netzker R, Hannappel E. β-Thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol. 2001;33(3):205-220. doi:10.1016/S1357-2725(00)00087-X

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.